Article information
La hipertensión arterial es una complicación muy frecuente en pacientes en hemodiálsis. Un elevado porcentaje de los pacientes tratados con hemodiálisis estándar permanecen hipertensos a pesar de tratamiento farmacológico intensivo. Presentamos el caso de una paciente hipertensa de difícil control con varios ingresos por complicaciones secundarias a pesar de tratamiento antihipertensivo con cinco fármacos. La HTA fue controlada con el cambio a un esquema de diálisis corta diaria con la progresiva suspensión del tratamiento farmacológico.
Palabras clave:
Hipertensión
Palabras clave:
Tratamiento antihipertensivo
Palabras clave:
hemodiálisis diaria
Palabras clave:
Dieta hiposódica
Hypertension is a very frequent complication in patients in hemodialysis. A high percentage of the patients on standard hemodialysis remain hypertense in spite of intensive pharmacologic treatment. We presented the case of a hypertense patient with difficult control in spite of antihypertensive treatment with five drugs and several secondary complications. The change to a short daily hemodialysis was successful to hypertension control and allowed a gradual suspension of drugs.
Keywords:
Hypertension
Keywords:
Antihypertensive treatment
Keywords:
Daily hemodyalisis
Keywords:
Hiposodic diet
Bibliography
[1]
Vincenti F, Amend W, Abele J. The role of hypertension in hemodialysis associated atherosclerosis. Am J Med 68: 363-369, 1980. [Pubmed]
[2]
Raine AE, Margreiter R, Brunner FP, Ehrich JH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, Valderrábano F. Report on manegement of renal failure in Europe, 1991. Nephrol Dial Transplant 7 (Supl. 2): S7-S35, 1992.
[3]
Cheigh JS, Milite C, Sullivan JF, Rubin AL, Stenzel KH. Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19: 453-459, 1992. [Pubmed]
[4]
Salem MM. Hypertension in the hemodialysis population: a survey of 649 patients. Am J Kidney Dis 26: 461-468, 1995. [Pubmed]
[5]
Maduell F. ¿Sacamos todo el partido a la hemodiálisis? Nefrología 23: 223-224, 2002.
[6]
López Gómez JM, Jofre, R Rodríguez Benítez R. Efecto de las diversas técnicas de hemodiálisis y hemodiafiltración sobre la hipertensión y riesgo cardiovascular. Nefrologia 24 (Supl. 1): 62-64, 2004.
[7]
Goicochea MA. Peculiaridades del tratamiento antihipertensivo en diálisis periódicas. Nefrología 24 (Supl. 6): 161-171, 2004. [Pubmed]
[8]
Scribner BH. Can antihypertensive medications control BP in haemodialysis patients: yes or no? Nephrol Dial Transplant 14: 2599-2601, 1999. [Pubmed]
[9]
Mailloux LU. The overlooked role of salt restriction in dialysis patients. Semin Dial 13: 150-151, 2000. [Pubmed]
[10]
Özkahya M, Töz H, Ünsal A, Özerkan F, Asci G, Gürgün C, Akçiçek F, Mees JD. Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 34: 218-221, 1999. [Pubmed]
[11]
Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 16: 35-44, 1996. [Pubmed]
[12]
Mastrangelo F, Alfonso L, Napoli M, DeBlasi V, Russo F, Patruno P. Dialysis with increased frequency of sessions (Lecce dialysis). Nephrol Dial Transplant 13 (Suppl 6): 139-147, 1998. [Pubmed]
[13]
Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M. Daily dialysis: Long-term clinical metabolic results. Kidney Int 33 (Supl. 24): S137-S140, 1988.
[14]
Hombrouckx R, Bogaert AM, Leroy F y cols. Limitations for short dialysis are the indications for ultra short daily auto dialysis. Trans ASAIO 35: 503-505, 1989.
[15]
Pincialori AR. Results of daily hemodialysis in Catanzaro: 12 years experience with 22 patients treated for more than one year. Home hemodial Int 2: 12-17, 1998.
[16]
Pincialori AR. Hormonal changes in daily hemodialysis. Semin Dial 12: 455-461, 1999.
